A new University of Cincinnati Cancer Center study has identified a particular strand of microRNA as a promising new target ...

Capricor's biologics license application for deramiocel (CAP-1002) is draws largely on the Phase 2 HOPE-2 trial and its ...

The charity’s much-loved events, which raise funds for life-saving research, are taking place in Ayr on June 1 and anyone who ...

Scientists from CSIR-Central Drug Research Institute have discovered that targeting the enzyme acyl-CoA synthetase 4 (ACSL4) ...

At 15 years, patients who had received immediate surgery had lower rates of distant recurrence and breast cancer death.

The following is a summary of “Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women ...